news Archives - Page 72 of 100 - Journal for Clinical Studies

Current Edition

news

Results of the Randomized, Double-Blind, Placebo-Controlled, Phase III HERCULES study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura to be presented at he 59th Annual Meeting of the American Society of Hematology

Ablynx NV [Euronext Brussels and Nasdaq: ABLX] has announced that results from its Phase III HERCULES study of caplacizumab have been selected as one of only six abst...

22 November 2017 news aTTP | caplacizumab

Continue Reading →

news

Khondrion Presents Phase II KHENERGY Trial Data

Khondrion, a leading clinical-stage pharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, today announced results from its KHENER...

22 November 2017 news data | double-blind

Continue Reading →

news

First Ever Effective Intervention Against Dementia Shown in Large Study

Researchers just published the first randomized controlled trial ever to show an intervention effective at lowering the risk of dementia. A computerized brain exerci...

22 November 2017 news Alzheimer | brain

Continue Reading →

news

Quanticate launches statistical monitoring services following the ICH GCP E6(R2) addendum

Quanticate, a data-focused clinical research organisation (CRO), has launched its centralised statistical monitoring service (https://www.quanticate.com/centralized-s...

22 November 2017 news clinical trial | data

Continue Reading →

news

PCI Clinical Services Announces Launch of a Mobile App for its Comprehensive Customer Support Portal Webflow™ – Enabling Further Efficient Clinical Supply Chain Management

PCI has today announced the launch of a mobile application (app) to provide more convenient access to its client services online portal Webflow™. Webflow™ is a...

16 November 2017 news app | mobile

Continue Reading →

news

Sage’s brexanolone meets primary endpoints in phase 3 postpartum depression trials

Sage Therapeutics has reported positive top-line results from two phase 3 clinical trials with its i.v. formulation of brexanolone (USAN; formerly SAGE-547); Study 20...

15 November 2017 news depression | postpartum

Continue Reading →

news

Novartis’ breast cancer drug Kisqali succeeds in phase 3 study in premenopausal women

Novartis’ Kisqali (ribociclib) combination therapy has succeeded in a phase 3 study in premenopausal women with hormone-receptor positive, human epidermal growth fact...

15 November 2017 news breast cancer | hormone

Continue Reading →

news

RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn’s Disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gast...

15 November 2017 news Crohn | enrolled

Continue Reading →

news

Clinical placebo study confirms medical evidence for the Antinitus patch as a treatment method for tinnitus

The results of a recent clinical placebo study indicates significant and statistically assured positive effects of the Antinitus patch for reducing discomfort from t...

15 November 2017 news clinical | development

Continue Reading →

news

Quotient Sciences Launches as the New Global Identity for Quotient Clinical

Quotient Clinical, the drug development services organization, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS ...

15 November 2017 news CDMO | clinical trial

Continue Reading →